The Relationship of GATA3 and Ki-67 With Histopathological Prognostic Parameters, Locoregional Recurrence and Disease-free Survival in Invasive Ductal Carcinoma of the Breast

被引:5
作者
Yildirim, Emine [1 ]
Bektas, Sibel [2 ]
Gundogar, Ozgecan [3 ]
Findik, Deniz [1 ]
Alcicek, Serap [1 ]
Erdogan, Kivilcim Orhun [1 ]
Yildiz, Mete [4 ]
机构
[1] Univ Hlth Sci Turkey, Gaziosmanpasa Training & Res Hosp, Dept Gen Surg, Osmanbey Cad 621, TR-34255 Istanbul, Turkey
[2] Univ Hlth Sci Turkey, Gaziosmanpasa Training & Res Hosp, Dept Pathol, Istanbul, Turkey
[3] Bahcelievler Govt Hosp, Dept Pathol, Istanbul, Turkey
[4] Duz Govt Hosp, Dept Gen Surg, Osmaniye, Turkey
关键词
Breast cancer; prognostic parameters; GATA3; Ki-67; CANCER; EXPRESSION; KI67; THERAPY; MARKERS; PROTEIN; WOMEN; STAGE;
D O I
10.21873/anticanres.14578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In recent years, GATA-binding protein 3 (GATA3) has been indicated as a marker showing good prognosis in breast cancer. In luminal breast cancer, which has good a prognosis, it shows more significant elevation in small-sized and low-grade tumors. In contrast, Ki-67 is defined as a poor prognostic factor. The aim of this study was to emphasise the prognostic importance of GATA3 and the inverse relationship with Ki-67. Materials and Methods: In our study, 90 patients with invasive ductal breast cancer were immunohistochemically evaluated for Ki-67 and GATA3 expression. The relationship between GATA3 and Ki-67 expression was examined. In addition, the relationship between these two factors with estrogen, progesterone, human epidermal growth factor 2 receptor antibodies and other prognostic parameters such as disease-free survival and local recurrence was investigated. We accepted the level of >= 5% nuclear reaction as positive for GATA 3. A Ki-67 cut-off value of 20% was accepted as positive. Results: In GATA3 positive breast cancers, good prognostic parameters were seen including high estrogen receptor (ER) positivity, progesterone receptor (PR) positivity, small tumor size and low histological grade as well as low Ki-67 expression. In breast cancers showing high Ki-67 expression, ER, PR, and GATA3 positivity were lower and there was higher human epidermal growth factor receptor 2 (HER2) positivity and high histological grade while the tumor size was larger. Conclusion: Our study has revealed that GATA3 has an inverse relationship with Ki-67, whereas it has a positive releationship with good prognostic factors.
引用
收藏
页码:5649 / 5657
页数:9
相关论文
共 38 条
[1]  
Ahmed Shatha Th, 2018, Asian Pac J Cancer Prev, V19, P955
[2]   P53 AND C-ERBB-2 PROTEIN EXPRESSION IN BREAST CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY INCLUDING CORRELATIONS WITH RECEPTOR STATUS, PROLIFERATION MARKERS, AND CLINICAL STAGE IN HUMAN BREAST-CANCER [J].
BARBARESCHI, M ;
LEONARDI, E ;
MAURI, FA ;
SERIO, G ;
PALMA, PD .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (04) :408-418
[3]   Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients [J].
de Azambuja, E. ;
Cardoso, F. ;
de Castro, G., Jr. ;
Colozza, M. ;
Mano, M. S. ;
Durbecq, V. ;
Sotiriou, C. ;
Larsimont, D. ;
Piccart-Gebhart, M. J. ;
Paesmans, M. .
BRITISH JOURNAL OF CANCER, 2007, 96 (10) :1504-1513
[4]  
FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO
[5]  
2-3
[6]  
Fitzgibbons P, CAP protocol for the examination of specimens from patients with invasive carcinoma of the breast
[7]  
GERDES J, 1991, AM J PATHOL, V138, P867
[8]   Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [J].
Goldhirsch, A. ;
Winer, E. P. ;
Coates, A. S. ;
Gelber, R. D. ;
Piccart-Gebhart, M. ;
Thuerlimann, B. ;
Senn, H. -J. .
ANNALS OF ONCOLOGY, 2013, 24 (09) :2206-2223
[9]   Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis [J].
Guo, Yawen ;
Yu, Pan ;
Liu, Zeming ;
Maimaiti, Yusufu ;
Chen, Chen ;
Zhang, Yunke ;
Yin, Xingjie ;
Wang, Shan ;
Liu, Chunping ;
Huang, Tao .
PLOS ONE, 2017, 12 (04)
[10]   American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer [J].
Harris, Lyndsay ;
Fritsche, Herbert ;
Mennel, Robert ;
Norton, Larry ;
Ravdin, Peter ;
Taube, Sheila ;
Somerfield, Mark R. ;
Hayes, Daniel F. ;
Bast, Robert C., Jr. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5287-5312